KS
Kunal Shinde
About Kunal Shinde
Data last updated:
Kunal Shinde is an Additional Director at Betabiopharm Private Limited (since 2025) and Additional Director at Bloomlife Pharma Private Limited (since 2025). The companies operate in Trading and Environment. The 2 current companies with reported revenue have a combined latest revenue of ₹68.11 Cr; the largest is Betabiopharm Private Limited at ₹34.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Betabiopharm Private Limited U51909GJ2022PTC135997 | Additional Director | 10 Jul 2025 | 2022 | ₹34.06 Cr (FY 2025) | Active |
 Bloomlife Pharma Private Limited U46497MP2017PTC043018 | Additional Director | 09 Jul 2025 | 2017 | ₹34.06 Cr (FY 2025) | Active |
Board colleagues of Kunal Shinde
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sonu Meena | 09758971 | Betabiopharm Private Limited , Bloomlife Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kunal Shinde
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kunal Shinde
Kunal Shinde currently holds 2 directorships: Betabiopharm Private Limited (Additional Director, since 10 Jul 2025, revenue ₹34.06 Cr (FY 2025)); Bloomlife Pharma Private Limited (Additional Director, since 09 Jul 2025, revenue ₹34.06 Cr (FY 2025)).
Kunal Shinde was first appointed on 09 Jul 2025 as Additional Director at Bloomlife Pharma Private Limited.
The 2 current companies of Kunal Shinde that report revenue have a combined latest revenue of ₹68.11 Cr: Betabiopharm Private Limited ₹34.06 Cr (FY 2025); Bloomlife Pharma Private Limited ₹34.06 Cr (FY 2025).
The current boards of Kunal Shinde's companies include Sonu Meena (Betabiopharm Private Limited).